OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the dual character of metformin in Alzheimer's disease
Pingping Ning, Anling Luo, Xin Mu, et al.
Neuropharmacology (2022) Vol. 207, pp. 108966-108966
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Gui Cao, Ting Gong, Yue Du, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113686-113686
Open Access | Times Cited: 52

Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1107-1115
Closed Access | Times Cited: 35

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33

Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access

Comparative efficacy and safety of antidiabetic agents in Alzheimer's disease: A network meta-analysis of randomized controlled trials
Zixin Cai, Jiaxin Zhong, Guanghui Zhu, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100111-100111
Open Access

Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Suad Hamdan Almasoudi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 224, pp. 111296-111296
Open Access

EPIC-1042 alleviates cerebral ischemic/reperfusion injury through TAX1BP1-induced mitophagy
Jiasheng Ju, Chao Cheng, Longtao Cui, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Metformin alleviates spinal cord injury by inhibiting nerve cell ferroptosis through upregulation of heme oxygenase-1 expression
Wang Zh, Wu Zhou, Zhixiong Zhang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 2041-2049
Open Access | Times Cited: 11

Metformin Improves Spatial Memory and Reduces Seizure Severity in a Rat Model of Epilepsy and Alzheimer’s Disease comorbidity via PI3K/Akt Signaling Pathway
Suélen Santos Alves, Letícia Rossi, José Antônio Cortes de Oliveira, et al.
Molecular Neurobiology (2025)
Closed Access

Comparison of various exercise interventions on cognitive function in Alzheimer's patients: A network meta-analysis
Shi Lv, Qian Wang, Wenxin Liu, et al.
Archives of Gerontology and Geriatrics (2023) Vol. 115, pp. 105113-105113
Closed Access | Times Cited: 10

Evaluation of Systemic and Brain Pharmacokinetic Parameters for Repurposing Metformin Using Intravenous Bolus Administration
Sejal Sharma, Yong Zhang, Dhaval Patel, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 3

Novel targets and therapies of metformin in dementia: old drug, new insights
Wenxing Cui, Chen Lv, Panling Geng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia
Ke Liu, Zhaoyuan Zhang, Yu Xu, et al.
Cellular Signalling (2024) Vol. 118, pp. 111125-111125
Open Access | Times Cited: 2

Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases
Neetu Rani, Aastha Kaushik, Shefali Kardam, et al.
Progress in molecular biology and translational science (2024), pp. 23-70
Closed Access | Times Cited: 2

The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial
Mohamed Y. Abdelgaied, Mohamed Hamed Rashad, Hend Mohamed El-Tayebi, et al.
Journal of Neurology (2023) Vol. 271, Iss. 3, pp. 1124-1132
Closed Access | Times Cited: 6

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
Amy Woodfield, Tatiana Gonzales, Erik Helmerhorst, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15811-15811
Open Access | Times Cited: 8

Biochemical bases of the organoprotective properties of metformin
A. S. Teplova, В. В. Титова, A. I. Tenchurina
FOCUS Endocrinology (2024) Vol. 5, Iss. 1, pp. 59-64
Open Access | Times Cited: 1

Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade
Liwei Li, Jinfeng Sun, Fan Chen, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1

Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial
Zahra Bazrafshan, Parsa Mohammadi, Alireza Hasanzadeh, et al.
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 1

Nutritional intervention for diabetes mellitus with Alzheimer's disease
Zhi Li, Simian Li, Ying Xiao, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 5

Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer’s disease: a meta-analysis
Haiyan Wang, Siyi Li, Jiwei Zhang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access

EFFECTIVENESS OF THE COMBINATION OF METFORMIN AND INTRANASAL INSULIN FOR THE CORRECTION OF METABOLIC AND HORMONAL DISTURBANCES IN ADULT MALE RATS WITH METABOLIC SYNDROME INDUCED BY IMPAIRED BREASTFEEDING
К. В. Деркач, Александр Олегович Иванцов, Н. Е. Басова, et al.
Reviews on Clinical Pharmacology and Drug Therapy (2024)
Closed Access

Page 1 - Next Page

Scroll to top